Transarterial chemoembolization in patients not eligible for liver transplantation: single-center results.
OBJECTIVE
The purpose of this study was to evaluate the effectiveness of transarterial chemoembolization in the care of patients not eligible for liver transplantation.


CONCLUSIONS
Prognosis depends on local response, Okuda score, alpha-fetoprotein level, and tumor size and is independent of the presence of portal venous thrombosis.
Herber
Sascha C A
SC
Department of Diagnostic and Interventional Radiology, University of Mainz, Langenbeckstr. 1, 55124 Mainz, Germany. s.herber@kk-koblenz.de
Otto
Gerd
G
Schneider
Jens
J
Schuchmann
Markus
M
Düber
Christoph
C
Pitton
Michael B
MB
Kummer
Inga
I
Manzl
Nicole
N
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage*; D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D016461:Chemoembolization, Therapeutic; D016009:Chi-Square Distribution; D003287:Contrast Media; D005260:Female; D006801:Humans; D007459:Iodized Oil / Q000008:administration & dosage*; D007479:Iopamidol / Q000031:analogs & derivatives; D008113:Liver Neoplasms / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D016685:Mitomycin / Q000008:administration & dosage*; D010166:Palliative Care; D011379:Prognosis; D018709:Statistics, Nonparametric; D016019:Survival Analysis; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D000903:Antibiotics, Antineoplastic; D003287:Contrast Media; C057937:iomeprol; D016685:Mitomycin; D007459:Iodized Oil; D007479:Iopamidol